
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.4B | -- | -- | $2.49 | -- |
08/01/2025 | Q2 | $1.2B | -- | -- | $1.70 | -- |
05/01/2025 | Q1 | $706.2M | $699.5M | -$0.77 | -$0.46 | -$0.32 |
02/13/2025 | Q4 | $949.9M | $977.3M | $0.84 | $1.24 | -$0.40 |
10/31/2024 | Q3 | $1.3B | $1.3B | $1.57 | $2.47 | -$0.90 |
08/01/2024 | Q2 | $1B | $1.1B | $0.76 | $1.39 | -$0.63 |
05/02/2024 | Q1 | $666.5M | $672.3M | -$0.70 | -$0.28 | -$0.42 |
02/22/2024 | Q4 | $838.9M | $933.7M | $0.55 | $0.89 | -$0.34 |
10/31/2023 | Q3 | -- | -- | $1.13 | $1.40 | -$0.27 |
07/27/2023 | Q2 | -- | -- | -$0.39 | $1.01 | -$1.40 |
05/02/2023 | Q1 | -- | -- | -$0.53 | -$0.09 | -$0.44 |
02/16/2023 | Q4 | -- | -- | $0.46 | $0.36 | $0.10 |
10/27/2022 | Q3 | -- | -- | $1.44 | $0.94 | $0.50 |
07/28/2022 | Q2 | -- | -- | $0.39 | $0.58 | -$0.19 |
04/28/2022 | Q1 | -- | -- | -$0.29 | -$0.32 | $0.03 |
02/25/2022 | Q4 | -- | -- | -$0.29 | $0.27 | -$0.56 |
10/28/2021 | Q3 | -- | -- | $0.73 | $0.85 | -$0.12 |
07/29/2021 | Q2 | -- | -- | $1.14 | $0.52 | $0.63 |
05/07/2021 | Q1 | -- | -- | -$1.45 | -$0.66 | -$0.79 |
03/30/2021 | Q4 | -- | -- | $0.17 | $0.49 | -$0.32 |
12/04/2020 | Q3 | -- | -- | -$2.00 | $1.22 | -$3.22 |
08/10/2020 | Q2 | -- | -- | $0.07 | $0.34 | -$0.27 |
06/26/2020 | Q1 | -- | -- | -$1.44 | -$0.77 | -$0.67 |
03/30/2020 | Q4 | -- | -- | -- | $0.30 | -- |
10/25/2019 | Q3 | -- | -- | $0.43 | $1.41 | -$0.98 |
08/02/2019 | Q2 | -- | -- | -$2.09 | -$2.05 | -$0.04 |
04/26/2019 | Q1 | -- | -- | -$0.74 | -$0.26 | -$0.48 |
02/20/2019 | Q4 | -- | -- | $0.14 | $0.96 | -$0.82 |
10/26/2018 | Q3 | -- | -- | $1.17 | $1.25 | -$0.08 |
08/08/2018 | Q2 | -- | -- | -$0.20 | $0.99 | -$1.19 |
04/30/2018 | Q1 | -- | -- | -$0.29 | -$0.36 | $0.07 |
02/16/2018 | Q4 | -- | -- | $0.81 | $0.70 | $0.11 |
10/27/2017 | Q3 | -- | -- | $1.14 | -- | -- |
08/01/2017 | Q2 | -- | -- | $0.35 | -- | -- |
05/02/2017 | Q1 | -- | -- | -$0.60 | -- | -- |
02/17/2017 | Q4 | -- | -- | $0.40 | -- | -- |
10/28/2016 | Q3 | -- | -- | $0.92 | -- | -- |
07/29/2016 | Q2 | -- | -- | $0.35 | -- | -- |
04/29/2016 | Q1 | -- | -- | -$0.26 | -- | -- |
02/25/2016 | Q4 | -- | -- | $0.72 | -- | -- |
11/02/2015 | Q3 | -- | -- | $0.77 | -- | -- |
Granite Construction reported $699.5M worth of top line sales in its most recent quarter.
Granite Construction announced earnings per share of -$0.77 which represents a miss of analyst forecast a -$0.46 per share.
Granite Construction reported $83.8M that represents $1.93 per share over the last quarter.
Granite Construction's earnings are forecast to grow from $2.62 per share to $4.37 per share next year representing an increase of 109.71%.
Granite Construction's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.